Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Assets (2016 - 2021)

Historic Return on Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to 0.15%.

  • Avadel Pharmaceuticals' Return on Assets rose 900.0% to 0.15% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.15%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.31% for FY2021, which is 2800.0% down from last year.
  • According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Return on Assets is 0.15%, which was up 900.0% from 0.26% recorded in Q2 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Return on Assets ranged from a high of 0.1% in Q1 2018 and a low of 0.6% during Q2 2019
  • Over the past 5 years, Avadel Pharmaceuticals' median Return on Assets value was 0.25% (recorded in 2021), while the average stood at 0.25%.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Return on Assets tumbled by -6700bps in 2018, and later surged by 5200bps in 2020.
  • Avadel Pharmaceuticals' Return on Assets (Quarter) stood at 0.41% in 2018, then fell by -19bps to 0.49% in 2019, then soared by 104bps to 0.02% in 2020, then plummeted by -1804bps to 0.34% in 2021, then surged by 56bps to 0.15% in 2022.
  • Its last three reported values are 0.15% in Q3 2022, 0.26% for Q2 2022, and 0.31% during Q1 2022.